The latest quarterly R&D expense is $5.60 Million with a QoQ Growth of -42.27%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q3 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q3 FY2026 (2026-06-30): $5.60M.
$5.60M
$5.60 Million
Q3 FY2026 · 2026-06-30
-42.27%
vs. $9.70M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q3 FY2026Period end 2026-06-30 | $5.60M | -42.27% | +47.37% |
| Q2 FY2026Period end 2026-03-31 | $9.70M | N/A | +162.16% |
| Q1 FY2026Period end 2025-12-31 | $300.00K | -93.48% | -96.84% |
| Q4 FY2025Period end 2025-09-30 | $4.60M | +21.05% | -76.77% |
| Q3 FY2025Period end 2025-06-30 | $3.80M | +2.70% | -81.37% |
| Q2 FY2025Period end 2025-03-31 | $3.70M | -61.05% | -79.89% |
| Q1 FY2025Period end 2024-12-31 | $9.50M | -52.02% | -52.97% |
| Q4 FY2024Period end 2024-09-30 | $19.80M | -2.94% | -16.10% |
| Q3 FY2024Period end 2024-06-30 | $20.40M | +10.87% | -9.73% |
| Q2 FY2024Period end 2024-03-31 | $18.40M | -8.91% | -16.74% |
| Q1 FY2024Period end 2023-12-31 | $20.20M | -14.41% | +19.53% |
| Q4 FY2023Period end 2023-09-30 | $23.60M | +4.42% | +38.82% |
| Q3 FY2023Period end 2023-06-30 | $22.60M | +2.26% | +58.04% |
| Q2 FY2023Period end 2023-03-31 | $22.10M | +30.77% | +22.78% |
| Q1 FY2023Period end 2022-12-31 | $16.90M | -0.59% | +1.20% |
| Q4 FY2022Period end 2022-09-30 | $17.00M | +18.88% | -11.46% |
| Q3 FY2022Period end 2022-06-30 | $14.30M | -20.56% | -8.92% |
| Q2 FY2022Period end 2022-03-31 | $18.00M | +7.78% | +27.66% |
| Q1 FY2022Period end 2021-12-31 | $16.70M | -13.02% | +19.29% |
| Q4 FY2021Period end 2021-09-30 | $19.20M | +22.29% | N/A |
| Q3 FY2021Period end 2021-06-30 | $15.70M | +11.35% | N/A |
| Q2 FY2021Period end 2021-03-31 | $14.10M | +0.71% | N/A |
| Q1 FY2021Period end 2020-12-31 | $14.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
